Preclinical and clinical study on [18F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer’s disease

被引:0
|
作者
MiaoMiao Xu
Jun Guo
JiaCheng Gu
LinLin Zhang
ZiHao Liu
Lin Ding
HongLiang Fu
YuFei Ma
Sheng Liang
Hui Wang
机构
[1] Xinhua Hospital,Department of Nuclear Medicine
[2] School of Medicine,Brain Injury Center, Department of Neurosurgery, Renji Hospital
[3] Shanghai Jiao Tong University,undefined
[4] School of Medicine,undefined
[5] Shanghai Jiao Tong University,undefined
[6] Shanghai Institute of Head Trauma,undefined
关键词
Alzheimer’s disease (AD); β-Amyloid; Amyloid imaging; Positron emission tomography (PET); [; F]DRKXH1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:652 / 663
页数:11
相关论文
共 50 条
  • [21] Asymmetric amyloid deposition in preclinical Alzheimer's disease: A PET study
    Kjeldsen, Pernille L.
    Parbo, Peter
    Hansen, Kim, V
    Aanerud, Joel F. A.
    Ismail, Rola
    Nissen, Peter H.
    Dalby, Rikke B.
    Damholdt, Malene F.
    Borghammer, Per
    Brooks, David J.
    AGING BRAIN, 2022, 2
  • [22] [18F]-Barbiturates as PET-tracers for Alzheimer's disease
    Zanda, Matteo
    Calamai, Elisa
    Dall'Angelo, Sergio
    Koss, David
    Mingarelli, Marco
    Schweiger, Lutz
    Welch, Andy
    Platt, Bettina
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [23] [18F]-Florbetapir PET in Alzheimer's Disease and Frontotemporal Dementia
    Langheinrich, Tobias C.
    Kobylecki, Christopher
    Hinz, Rainer
    Vardy, Emma R.
    Casado, Maria E. Martino
    Schmidt, Cathleen
    Richardson, Anna M.
    Snowden, Julie
    Rodriguez, Jose Anton
    Neary, David
    Mann, David D.
    Gerhard, Alex
    Herholz, Karl
    ANNALS OF NEUROLOGY, 2013, 74 : S89 - S90
  • [24] FLUTEMETAMOL (18F): A β-AMYLOID POSITRON EMISSION TOMOGRAPHY TRACER FOR ALZHEIMER'S AND DEMENTIA DIAGNOSIS
    de Lartigue, J.
    DRUGS OF TODAY, 2014, 50 (03) : 219 - 229
  • [25] Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
    Harada, Ryuichi
    Lerdsirisuk, Pradith
    Shimizu, Yuki
    Yokoyama, Yuka
    Du, Yiqing
    Kudo, Kaede
    Ezura, Michinori
    Ishikawa, Yoichi
    Iwata, Ren
    Shidahara, Miho
    Ishiki, Aiko
    Kikuchi, Akio
    Hatano, Yuya
    Ishihara, Tomohiko
    Onodera, Osamu
    Iwasaki, Yasushi
    Yoshida, Mari
    Taki, Yasuyuki
    Arai, Hiroyuki
    Kudo, Yukitsuka
    Yanai, Kazuhiko
    Furumoto, Shozo
    Okamura, Nobuyuki
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (09) : 1495 - 1501
  • [26] Preclinical Evaluation of [18F]beta-CFT-FP, a Novel PET Tracer for Dopamine Transporter
    Koivula, T.
    Marjamaki, P.
    Fagerholm, V.
    Gronroos, T.
    Perhola, O.
    Lipponen, T.
    Haaparanta, M.
    Solin, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S43 - S43
  • [27] Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease
    Okamura, Nobuyuki
    Yanai, Kazuhiko
    IDRUGS, 2010, 13 (12) : 890 - 899
  • [28] [18F]-D3FSP β-amyloid PET imaging in older adults and alzheimer's disease
    Li, Anqi
    Zhao, Ruiyue
    Zhang, Mingkai
    Sun, Pan
    Cai, Yue
    Zhu, Lin
    Kung, Hank
    Han, Ying
    Wang, Xinlu
    Guo, Tengfei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (13) : 3990 - 4000
  • [29] Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study
    Edison, P.
    Archer, H. A.
    Hinz, R.
    Hammers, A.
    Pavese, N.
    Tai, Y. F.
    Hotton, G.
    Cutler, D.
    Fox, N.
    Kennedy, A.
    Rossor, M.
    Brooks, D. J.
    NEUROLOGY, 2007, 68 (07) : 501 - 508
  • [30] Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer's disease
    Lin, Huan-Chun
    Lin, Kun-Ju
    Huang, Kuo-Lun
    Chen, Shih-Hsin
    Ho, Tsung-Ying
    Huang, Chin-Chang
    Hsu, Jung-Lung
    Chang, Chiung-Chih
    Hsiao, Ing-Tsung
    FRONTIERS IN NEUROSCIENCE, 2023, 17